Stemline Therapeutics, Inc. Net Profit Margin 2013-2020 | STML
Stemline Therapeutics, Inc. net profit margin from 2013 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2020-03-31 |
$0.05B |
$-0.07B |
-151.06% |
2019-12-31 |
$0.04B |
$-0.08B |
-179.07% |
2019-03-31 |
$0.01B |
$-0.09B |
-1566.67% |
2018-06-30 |
$0.00B |
$-0.08B |
-7500.00% |
2017-12-31 |
$0.00B |
$-0.07B |
inf% |
2017-09-30 |
$0.00B |
$-0.06B |
inf% |
2017-06-30 |
$0.00B |
$-0.05B |
inf% |
2017-03-31 |
$0.00B |
$-0.04B |
inf% |
2016-12-31 |
$0.00B |
$-0.04B |
inf% |
2016-09-30 |
$0.00B |
$-0.04B |
inf% |
2016-06-30 |
$0.00B |
$-0.04B |
inf% |
2016-03-31 |
$0.00B |
$-0.04B |
inf% |
2015-12-31 |
$0.00B |
$-0.04B |
inf% |
2015-09-30 |
$0.00B |
$-0.03B |
inf% |
2015-06-30 |
$0.00B |
$-0.03B |
inf% |
2015-03-31 |
$0.00B |
$-0.03B |
inf% |
2014-12-31 |
$0.00B |
$-0.03B |
inf% |